NCT07148050
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Clinical trial condition
Liver Cell Carcinoma
Explore clinical trials studying Liver Cell Carcinoma. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Liver Cell Carcinoma trial results
NCT05366829
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Montefiore Medical Center The Bronx, New York, United States
Not Yet Recruiting
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
NCT07224568
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
- Locations
-
- Fred Hutch Cancer Center Seattle, Washington, United States
Not Yet Recruiting
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
NCT05195294
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
- Locations
-
Not specified
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Local Institution - 0010 Ciudad de Buenos Aires, Buenos Aires, Argentina
- Local Institution - 0019 Buenos Aires, Distrito Federal, Argentina
- Local Institution - 0017 Rosario, Santa Fe Province, Argentina
- Local Institution - 0063 San Miguel de Tucumán, Tucumán Province, Argentina
Active, Not Recruiting
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
NCT05103631
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States